Paclitaxel/carboplatin/bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

Dumoulin, D., de Goeje, P., Poncin, M., Bezemer, K., Groen, H. J. M., Smit, E. F., Dingemans, A-M. C., Kunert, A., Hendriks, R. & Aerts, J. G., Apr-2019, In : Annals of Oncology. 30, 1 p.

Research output: Contribution to journalMeeting AbstractAcademic

  • D. Dumoulin
  • P. de Goeje
  • M. Poncin
  • K. Bezemer
  • H. J. M. Groen
  • E. F. Smit
  • A-M. C. Dingemans
  • A. Kunert
  • R. Hendriks
  • J. G. Aerts
Original languageEnglish
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - Apr-2019
EventEuropean Lung Cancer Congress (ELCC) - Geneva, Switzerland
Duration: 10-Apr-201913-Apr-2019


European Lung Cancer Congress (ELCC)


Geneva, Switzerland

Event: Conference

ID: 94295777